share_log

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

SEC ·  May 7 16:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more